SCHEMBL6798674

SCHEMBL6798674

CC(=O)/C=C/c1cc(F)ccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.45
MAPT P10636 2/20 0.44
LMNA P02545 1/20 0.44
IAPP P10997 2/20 0.42
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.41
GLA P06280 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GAA P10253 1/20 0.40
TDO2 P48775 1/20 0.40
PTGS1 P23219 1/20 0.40
AR P10275 2/20 0.39
MAOB P27338 1/20 0.38
NPC1 O15118 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC8 Q9BY41 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6798679 1.00 KDM4E (0.45) KDM4EMAPTLMNAIAPPKMT2A
SCHEMBL4922283 0.84 TDO2 (0.55) KDM4EMAPTLMNATDO2HTT
SCHEMBL7687335 0.84 MAPT (0.46) KDM4EMAPTLMNAIAPPKMT2A
SCHEMBL7687333 0.84 MAPT (0.46) KDM4EMAPTLMNAIAPPKMT2A
SCHEMBL4922284 0.84 TDO2 (0.55) KDM4EMAPTLMNATDO2HTT
SCHEMBL7681007 0.82 MAPT (0.44) KDM4EMAPTLMNAIAPPKMT2A
SCHEMBL7681012 0.82 MAPT (0.44) KDM4EMAPTLMNAIAPPKMT2A
SCHEMBL20152957 0.82 BACE1 (0.51) KDM4EMAPTLMNAIAPPKMT2A
SCHEMBL6793792 0.81 NFE2L2 (0.53) KDM4EMAPTLMNAIAPPKMT2A
SCHEMBL30022725 0.81 NFE2L2 (0.53) KDM4EMAPTLMNAIAPPKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6706732-B1 PROPHYLACTIC AND THERAPEUTIC EFFECT ON MYOCARDIAL INFARCTION AND ACCOMPANYING DYSFUNCTIONS, ARRHYTHMIA, UNSTABLE ANGINA, CARDIAC HYPERTROPHY, ETC.; SODIUM-PROTON EXCHANGE INHIBITION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-16 US disclosed
EP-1182194-A1 PERNASAL PREPARATIONS Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed
US-6350749-B1 SODIUM CHANNEL MODULATORS, ANTIARRHYTHMIA AND HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS, ANGINA PECTORIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-02-26 US disclosed
EP-1057812-A1 AMINOGUANIDINE HYDRAZONE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND DRUGS THEREOF Takeda Chemical Industries, Ltd. (JP) 2000-12-06 EP disclosed
EP-0950418-A2 Composition for preventing or treating ischemic disease Takeda Chemical Industries, Ltd. (JP) 1999-10-20 EP disclosed